MARA Holdings
MARA
MicroStrategy
MSTR
Coinbase
COIN
Tesla
TSLA
Amazon
AMZN
US Stock MarketDetailed Quotes
NBIX Neurocrine Biosciences
- 143.260
- +1.340+0.94%
Close Jan 17 16:00 ET
- 143.260
- 0.0000.00%
Post 16:20 ET
14.50BMarket Cap38.20P/E (TTM)
144.820High141.570Low976.52KVolume142.850Open141.920Pre Close140.04MTurnover0.98%Turnover Ratio58.00P/E (Static)101.25MShares157.98052wk High5.33P/B14.34BFloat Cap110.95052wk Low--Dividend TTM100.08MShs Float157.980Historical High--Div YieldTTM2.29%Amplitude1.940Historical Low143.403Avg Price1Lot Size
About Neurocrine Biosciences Company
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.
Company Profile
SymbolNBIX
Company NameNeurocrine Biosciences
Listing DateMay 23, 1996
Issue Price10.50
Founded1992
CEODr. Kyle W. Gano, PhD
MarketNASDAQ
Employees1400
Fiscal Year Ends12-31
Address6027 Edgewood Bend Court
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-858-617-7600
Websitehttp://www.neurocrine.com
Company Executives
- Name
- Position
- Salary
- Dr. Kyle W. Gano, PhD
- Chief Executive Officer, President, Chief Business Development and Chief Strategy Officer
- 5.99M
- Dr. Jude Onyia, PhD
- Chief Scientific Officer
- 7.22M
- Dr. Eiry W. Roberts, M.D.
- Chief Medical Officer
- 5.87M
- Matthew C. Abernethy
- Chief Financial Officer and Principal Accounting Officer
- 6.06M
- Eric S. Benevich
- Chief Commercial Officer
- --
- Julie S. Cooke
- Chief Human Resources Officer
- --
- Ingrid Delaet
- Chief Regulatory Officer
- --
- David W. Boyer
- Chief Corporate Affairs Officer
- --
- Darin M. Lippoldt
- Chief Legal Officer and Corporate Secretary
- --
- Dr. William H. Rastetter,PhD
- Chairman of the Board
- 495.04K
- Dr. Kevin C. Gorman,PhD
- Director
- 15.75M
- Dr. Stephen A. Sherwin, M.D.
- Independent Director
- 479.54K
- Christine A. Poon
- Independent Director
- 813.45K
- Johanna Mercier
- Independent Director
- 467.61K
- Richard F. Pops
- Independent Director
- 492.04K
- Leslie V. Norwalk, Esq.
- Independent Director
- 475.11K
- Gary A. Lyons
- Independent Director
- 460.11K
- Shalini Sharp
- Independent Director
- 497.11K
- George J. Morrow
- Independent Director
- 479.54K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.